PRO 140 for Human Immunodeficiency Virus Infection
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Jacobson, MD
Drexel University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University (stanford Aids Clinical Trials Unit)
Stanford, California, United States
- University of Colorado Denver (colorado Actu)
Denver, Colorado, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center at Houston (houston Aids Research Team (hart)
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2014
- Primary completion
- 28 Feb 2015
- Completion
- 28 Feb 2015
- Last update posted
- 9 Mar 2017
- Registered enrollment
- 0
- Registry id
- NCT02257788
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.